UTA researchers publish review on potential use of long non-coding RNA as biomarkers for cancer and for novel gene therapies
Researchers at the University of Texas at Arlington have published a review article in the prestigious journal Cancer Research on the potential use of long non-coding RNA or lncRNA as novel biomarkers and therapeutic targets for cancer. The human genome encodes more than 28,000 distinct lncRNA, which are ribonucleic acid molecules that are not translated or coded into proteins. Next-generation gene sequencing techniques have revealed that thousands of lncRNA are associated with various types of cancers.